Cleo C L van Aanhold (Cleo van Aanhold)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Diabetic Nephropathy

High Fat Diet Induced

Tyrosine Kinase

Ischemia Reperfusion Injury

Top Venues

Scientific reports

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Cleo C L van Aanhold, Angela Koudijs, Kyra L Dijkstra, Ron Wolterbeek, Jan A Bruijn, Cees van Kooten, Hans Jacobus Baelde
The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition. International journal of molecular sciences 23 (17) (2022)
Cleo C L van Aanhold, Manon Bos, Katrina M Mirabito Colafella, Marie-Louise P van der Hoorn, Ron Wolterbeek, Jan A Bruijn, Kitty W M Bloemenkamp, Anton H van den Meiracker, A H Jan Danser, Hans J Baelde
Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia. Scientific reports 11 (1) (2021)
Inge Everaert, Thibaux Van der Stede, Jan Stautemas, Maxime Hanssens, Cleo C L van Aanhold, Hans Jacobus Baelde, Lynn Vanhaecke, Wim Derave
Oral anserine supplementation does not attenuate type-2 diabetes or diabetic nephropathy in BTBR ob/ob mice. Amino acids 53 (8) (2021)